Major points considered

7/30/01


Click here to start


Table of Contents

PPT Slide

Major points considered

EWG Charge

Biomarker Definition

Characteristics of an ideal biomarker

Key Questions

List of Current Cardiotoxicity Biomarkers

Cardiotoxicity Biomarkers on the [Near] Horizon

Identification & Validation of New Biomarkers - Interagency Coordinating Committee on Validation of Alternative Methods (ICCVAM)

Identification & Validation of New Biomarkers - Toxicologist Consensus

How can the FDA enable this process? - Confidentiality

How can the FDA enable this process? - Financial support

Next Steps in Fulfilling EWGs Charge

Possible outcomes?

Author: Kendall B. Wallace, Ph.D.